MedPath

Study for comparison between two types of refractive surgeries(for spectacle removal) one involving creating a flap in cornea(black part of eye)-lasik and one without a flap- ReLEx SmILE

Not Applicable
Conditions
Health Condition 1: null- Healthy Patients with Short Sightedness
Registration Number
CTRI/2014/09/005040
Lead Sponsor
ethradhama Superspeciality Eye Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

•SINGLE SURGEON

•MYOPIA BETWEEN 1D TO 10D SPHERICAL EQUIVALENT/AMOUNT OF ASTIGMATISM LESS THAN 5D

•AGE ABOVE 21 YEARS AND LESS THAN 40 YEARS.

•STABLE REFRACTION FOR ATLEAST 6MNTHS- 1 YEAR

•SOFT CONTACT LENS DISCONTINUED FOR MINIMUM 1 WEEK AND RIGID GAS PERMEABLE CONTACT LENS DISCONTINUED FOR MINIMUM 3 WEEKS

•CORNEAL TOPOGRAPHY-MINIMUM CORNEAL THICKNESS 480µ, RESIDUAL CORNEAL THICKNESS ATLEAST 250µ/50% OF ORIGINAL THICKNESS (WHICHEVER IS HIGHER)

Exclusion Criteria

•EVIDENCE OF OCULAR DISEASES LIKE MEIBOMIAN GLAND DISEASES, HERPETIC KERATITIS, UVIETIS, GLAUCOMA, VISUALLY SIGNIFICANT CATARACT, RETINAL DISEASES LIKE RETINAL DYSTROPHIES OR DIABETIC RETINOPATHY.

•PROGRESSIVE/UNSTABLE MYOPIA AND/OR ASTIGMATISM

•ANY PATHOLOGIES OF CORNEA LIKE CORNEAL DYSTROPHIES INCLUDING KERATOCONUS,ANY H/O CORNEAL TRAUMA OR SURGERY WITHIN FLAP ZONE

•DRY EYE STATUS-SCHIRMERâ??S 2 TEST VALUE LESS THAN 10 mm

•OCULAR MEDICATION LIKE β BLOCKERS.

•TAKING ANY SYSTEMIC MEDICATION LIKELY TO AFFECT WOUND HEALING LIKE CORTICOSTEROIDS OR ANTIMETABOLITES.

•H/O IMMUNOCOMPROMISED STATE OR PREGNANCY OR NURSING MOTHERS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare-visual outcome;dry eye status;corneal topography;contrast sensitivity;subjective pain assessment and patient satisfaction between the two proceduresTimepoint: DAY 1,15 AND 90.
Secondary Outcome Measures
NameTimeMethod
ANY COMPLICATIONS OF SURGERYTimepoint: DAY 1, 15 AND 90
© Copyright 2025. All Rights Reserved by MedPath